___

• 1. Okada N, Hanafusa T, Abe S, Sato C, Nakamura T, Teraoka K, et al. Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention. Support Care Cancer 2016;24(9):3979–85.
• 2. Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer 2008;16,275–83.
• 3. Speck RM, DeMichele A, Farrar JT, Hennessy S, Mao JJ, Stineman MG, et al. Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies. Support Care Cancer 2013;21:549–55.
• 4. Gamper EM, Zabernigg A, Wintner, LM, Giesinger J M., Oberguggenberger A, Kemmler G, et al. Coming to your senses: detecting taste and smell alterations in chemotherapy patients. A systematic review. J Pain Symptom Manage 2012;44(6):880–95.
• 5. Spotten L, Corish C, Lorton C, Dhuibhir PU, O’Donoghue N, O’Connor B, et al. Subjective taste and smell changes in treatment-naive people with solid tumours. Support Care Cancer 2016; 24:3201–08.
• 6. Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 2007;33:156–65.
• 7. Brisbois TD, de Kock IH, Watanabe SM., Baracos VE, Wismer WV. Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life. J Pain Symptom Manage. 2011;41:673–83.
• 8. Grant M, Kravits K. Symptoms and their impact on nutrition. In Semin Oncol Nurs 2000;16:113–21.
• 9. Ravasco P. Aspects of taste and compliance in patients with cancer. Eur J Oncol Nur 2005;9:84–91.
• 10.Sánchez-Lara K, Sosa-Sánchez R, Green-Renner D, Rodríguez C, Laviano A, Motola-Kuba D, et al. Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 2010;24:9–15.
• 11.Coa KI, Epstein JB, Ettinger D, Jatoi A, McManus K, Platek ME, et al. The impact of cancer treatment on the diets and food preferences of patients receiving outpatient treatment. Nutr Cancer 2015;67:339–53.
• 12.Ponticelli E, Clari M, Frigerio S, De Clemente A, Bergese I, Scavino E, et al. Dysgeusia and health‐related quality of life of cancer patients receiving chemotherapy: A cross‐sectional study. Eur J Cancer Care 2017;26(2)1–7.
• 12.McGreevy J, Orrevall Y, Belqaid K, Wismer W, Tishelman C, Bernhardson. Characteristics of taste and smell alterations reported by patients after starting treatment for lung cancer. Support Care Cancer 2014;22:2635–44.
• 13.Ottery FD. Definition of standardized nutritional assessment and interventional pathways in oncology. Nutrition 1996;12:15–9.
• 14.Bauer J, Capra S, Ferguson M. Use of the scored Patient-Generated Subjective Global Assessment (PGSGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 2002;56:779–85.
• 15.https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03/ CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
• 16.Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum 2013;40,79–85.
• 17.Sozeri E, Kutlutürkan S. The validity and reliability of Turkish version of the chemotherapy-induced taste alteration scale (CiTAS). Clin Nurs Res 2018;27(2):235–49.
• 18.Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002;30:785–92.
• 19.Zabernigg A, Gamper EM, Giesinger J M, Rumpold G, Kemmler G, Gattringer K, et al. Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?. Oncologist 2010;15:913–20.
• 20.IJpma I, Timmermans ER, Renken RJ, Ter Horst GJ, Reyners AK. Metallic taste in cancer patients treated with systemic therapy: A questionnaire-based study. Nutr Cancer 2017;69:140–5.
• 21.Strasser F, Demmer R, Böhme C, Schmitz SF, Thuerlimann B, Cerny T, et al. Prevention of docetaxel- or paclitaxel associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. Oncologist 2008;13(3):337–46.
• 22.Sözeri E, Kutlutürkan S.Taste Alteration in Patients Receiving Chemotherapy. J Breast Health 2015;11:81–7.
• 23.Farrell C, Brearley SG, Pilling M, Molassiotis A. The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer 2013;21:59–66.
• 24.Yamagishi A, Morita T, Miyashita M, Kimura F. Symptom prevalence and longitudinal follow-up in cancer outpatients receiving chemotherapy. J Pain Symptom Manage 2009;37:823–30.
• 25.Boussios S, Pentheroudakis G, Katsanos K, Pavlidis N. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management. Ann Gastroenterol 2012;25:106–18.
• 26.Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, OhrnK E, Elting LS, et a.l A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 2010;18:1081–7.
• 27.Turcott JG, Juárez-Hernández E, De la Torre-Vallejo M, Sánchez-Lara K, Luvian-Morales J, Arrieta O. Value: Changes in the Detection and Recognition Thresholds of Three Basic Tastes in Lung Cancer Patients Receiving Cisplatin and Paclitaxel and Its Association with Nutritional and Quality of Life Parameters. Nutr Cancer 2016;68(2):241–9.
• 28.Bernhardson BM, Tishelman C, Rutqvist LE. Taste and smell changes in patients receiving cancer chemotherapy: distress, impact on daily life, and self-care strategies. Cancer Nurs 2009;32:45–54.